Skip to search formSkip to main contentSkip to account menu

Rz967

Known as: hammerhead ribozyme Rz967 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
We have investigated the chemical basis for a previously observed 7.8 A conformational change in the hammerhead ribozyme that… 
Highly Cited
2002
Highly Cited
2002
The phenomenon of multidrug resistance (MDR) in human cancers is one of the major causes of failure of chemotherapy. A recently… 
Highly Cited
2001
Highly Cited
2001
Telomerase activity is necessary and sufficient for immortality in many cells and hence represents a prime target for antitumor… 
Highly Cited
1997
Highly Cited
1997
The bcl‐2 oncoprotein suppresses apoptosis and, when overexpressed in prostate cancer cells, makes these cells resistant to a… 
Highly Cited
1997
Highly Cited
1997
The length requirements of the antisense portion of hammerhead ribozymes for efficacy in living cells was investigated. The HIV… 
Highly Cited
1997
Highly Cited
1997
A hammerhead ribozyme that was previously reported to have a rate of chemical cleavage 10-fold faster than that of conventional… 
Highly Cited
1996
Highly Cited
1996
We have synthesized 13 hammerhead ribozyme variants, each containing an abasic residue at a specific position of the catalytic… 
Highly Cited
1996
Highly Cited
1996
The hammerhead ribozyme undergoes an ion-dependent folding process into the active conformation. We find that the folding can be…